Free
Corrections  |   August 2009
Correction
Article Information
Corrections   |   August 2009
Correction
The Journal of the American Osteopathic Association, August 2009, Vol. 109, 399. doi:10.7556/jaoa.2009.109.8.399
The Journal of the American Osteopathic Association, August 2009, Vol. 109, 399. doi:10.7556/jaoa.2009.109.8.399
The author regrets the omission of financial disclosures for the following article: 

Peterlin BL. The role of the adipocytokines adiponectin and leptin in migraine. J Am Osteopath Assoc. 2009;109:314-317. http://www.jaoa.org/cgi/content/full/109/6/314. Accessed July 21, 2009.

 
Dr Peterlin reports that she has received honoraria or grants from GlaxoSmithKline plc; Endo Pharmaceuticals; Merck & Co Inc; Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals Inc; and Pfizer Inc. In addition, she has a patent for the use of adiponectin-modulating agents in migraine. 
These disclosures were added to the full text (http://www.jaoa.org/cgi/content/full/109/6/314) and Adobe Portable Document Format (http://www.jaoa.org/cgi/reprint/109/6/314) versions of this article online.♦